Last reviewed · How we verify

NCT03959852

Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain

Terminated Phase 4 Last updated 11 September 2020
What this trial tests

Phase 4 trial testing Fentanyl in Pain, Acute in 6 participants. Terminated before completion.

Timeline
18 November 2019
Primary endpoint
5 June 2020
5 June 2020

Quick facts

Lead sponsorMercy Health Ohio
PhasePhase 4
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment6
Start date18 November 2019
Primary completion5 June 2020
Estimated completion5 June 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mercy Health Ohio — full company profile →

Who can join

Adults 18 to 65, any sex, with Pain, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to evaluate the potential opioid-sparing effect associated with the novel combination of fentanyl and sub-dissociative ketamine in adult patients with moderate to severe pain in the emergency department.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Fentanyl

Trials testing the same drug.

Other recruiting trials for Pain, Acute

Currently open trials in the same condition.

Other Mercy Health Ohio trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03959852.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing